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Hexavalent chromium Cr(VI) is a very strong oxidant which consequently causes high cytotoxicity through oxidative stress.
Prevention of Cr(VI)-induced cellular damage has been sought in this study in aqueous and methanolic extracts of Lawsonia
inermis Linn. (Lythraceae), commonly known as Henna. The extracts showed signiﬁcant (P < .05) potential in scavenging free
radicals (DPPH• and ABTS•+)a n dF e 3+, and in inhibiting lipid peroxidation. DNA damage caused by exposure of pBR322 to
Cr(VI)-UVismarkedlyinhibitedbybothextractsinvaryingdegrees.AdistinctdeclineinCr(VI)-inducedcytotoxicitywasnoticed
in MDA-MB-435S (human breast carcinoma) cells with an increase in dosage of both extracts individually. Furthermore, both
extracts proved to contain a high content of phenolic compounds which were found to have a strong and signiﬁcant (P < .05)
positivecorrelationtotheradicalscavenging potential,lipidperoxidationinhibitioncapacity andcyto-protectiveeﬃciency against
Cr(VI)-induced oxidative cellular damage. HPLC analysis identiﬁed some of the major phenolic compounds in both extracts,
which might be responsible for the antioxidant potential and the properties of DNA and cyto-protection. This study contributes
to the search for natural resources that might yield potent therapeutic drugs against Cr(VI)-induced oxidative cell damage.
1.Introduction
Hexavalent chromium [Cr(VI)] is the most toxic and
mutagenic heavy metal in biological systems [1]. It exists
as oxo-species such as CrO3 and CrO2−
4 , which are robustly
oxidizing [2], leading to excessive cytotoxicity that in turn
may cause dermal damage, gastrointestinal bleeding, renal
failure,intravascularhemolysis,liverdamage,comaandeven
death [3]. Cr(VI) is transported into cells through the sulfate
transporter[4], and leads to alteration of signal transduction
pathways [5], cell transformation [6], and increases the
risk for developing cancer [7]. Simultaneously, it is also
known to inhibit cell proliferation/cell cycle [8], thereby
inducing growth arrest, accompanied by the generation
of reactive oxygen species (ROS) that presumably triggers
oxidativedamagetoDNA[9]andconsequentapoptosis[10].
Oxidative damage is associated with the generation of free
radicals in cells exposed to Cr(VI) ion, and a propensity of
cells to develop mutations in response to Cr(VI)-induced
oxidative damage has been reported [11, 12].
Sources of Cr(VI) toxicity are broadly classiﬁed into
occupational and non-occupational exposure types. Highest
occupational exposures to Cr(VI) occur during chromate
production, welding, chrome pigment manufacture, chrome
plating and spray painting. Non-occupational sources of
exposure include food, air and water [7].
Various compounds with diﬀerential antioxidant prop-
erties are found in ﬂoral resources which are considered to
have high potential in context of therapeutic approaches to
encounter and prevent free radical damage as that caused
by Cr(VI) toxicity. Lawsonia inermis Linn. (Lythraceae),
commonly known as Henna, is a popular skin and hair
coloring agent in many parts of the world. In addition, it
is traditionally used as a medicinal plant [13]b yd i v e r s e
groups of tribal/ethnic people [14–16]. Lawsonia inermis
is used as an antirheumatic and antineuralgic agent [15],
and also has potential as an antidiabetic drug [16]. There
is evidence of the plant having wound healing properties
[17]. Furthermore, treatment with hydroalcoholic extract of
L. inermis (in vivo) has been proved to increase levels of
cellular antioxidant enzymes such as glutathione reductase,
superoxide dismutase and catalase [18].
This study was aimed at evaluating the eﬀects of aqueous
and methanolic extracts of L. inermis on induced oxidative2 Evidence-Based Complementary and Alternative Medicine
toxicity in MDA-MB-435S (human breast carcinoma) cells,
along with an estimation of the compositions of these
extracts and their respective antioxidant potential.
2. Methods
2.1.ChemicalsandReagents. Chromiumtrioxide(CrO3),thi-
obarbituric acid(TBA),phenazine methosulfate(PMS)(also
known as N-methylphenazonium methosulfate), L-15 (Lei-
bovitz) cell culture medium (with l-glutamine), 2,2-diphe-
nyl-1-picrylhydrazyl (DPPH), Dulbecco’s phosphate buﬀe-
red saline (PBS) (Ca2+/Mg2+-free) and 2,4,6-tri- pyridyl-s-
triazine (TPTZ) were purchased from Himedia Laboratories
Pvt Ltd (India). Trolox (6-hydroxy-2,5,7,8-tetramethyl chro-
man-2-carboxylic acid) and 2,2 -azino-bis(3-ethylbenz-thia-
zoline-6-sulfonic acid) (ABTS) were procured from Sigma
Aldrich Chemical Co. (Milwaukee, WI, USA). MDA-MB-
435S cell line was obtained from National Center for Cell
Science (Pune, India). XTT {2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium
hydroxide}wasobtainedfromSigmaChemicalCo.(StLouis,
MO, USA). pBR322 was obtained from Medox Biotech India
Pvt Ltd (India). The remaining chemicals and solvents used
were of standard analytical grade and HPLC grade, respe-
ctively.
2.2. Plant Material. Lawsonia inermis Linn. (whole plant)
was collected in the month of May 2007 from Vellore district
(12◦55 N, 79◦11 E), Tamil Nadu, India, and identiﬁed at
Botanical Survey of India, Southern Circle, Coimbatore,
Tamil Nadu, India. Voucher specimens are maintained
at our laboratory for future references (Accession no.:
VIT/SBCBE/CCL/07/5/03; May 12, 2007).
2.3. Processing and Extraction. Healthy plants were screened
for contamination by other species and thoroughly washed.
The cleansed plants were freeze dried for 2 months at
−80
◦Ci na nM D F - U 3 2 VV . I . P .S e r i e s−86
◦C Ultra-Low
TemperatureFreezer(SanyoBiomedical,IL,USA).Thedried
plants were powdered for the preparation of extracts. Whole
plant powder was serially extracted with methanol and
water using Soxhlet apparatus. These crude extracts were
concentrated at 40
◦C under reduced pressure (72mbar for
aqueous extract; 337mbar for methanolic extract) with a
Rotavapor R-215 (B¨ UCHI Labortechnik AG, Switzerland) to
yield dry extracts. Percentage yields of the methanolic and
aqueous extracts were, respectively, 19.58% and 10.42% of
dry weight.
2.4. Estimation of Antioxidant Potential: Radical
Scavenging and Inhibition of Lipid Peroxidation
2.4.1. DPPH Radical Scavenging Activity. The DPPH assay
was performed according to the method of Brand-Williams
et al. [19] with a few modiﬁcations. 2mL of extract solution
(10, 20, 40, 60, 80, and 100μgmL
−1) made in methanol
was added to 1mL of DPPH
• solution (0.2mMmL
−1
methanol)andmixedvigorously.Themixturewasincubated
in darkness at 20◦C for 40min. Absorbance was measured at
517 nm using a Cary 50 UV-Vis spectrophotometer (Varian,
Inc., CA, USA) with methanol as blank. Trolox was used
as positive control. The level of percentage scavenging of
DPPH
• by the extracts was calculated according to the
following formula:
% radical scavenging =
(AC −A)
A
×100

,( 1 )
where AC is the absorbance of the control and A is
the absorbance of sample. Percentage scavenging was also
expressed as Trolox equivalence (in μgmL
−1).
2.4.2. ABTS Radical Scavenging Activity. ABTS assay was
performed according to the protocol of Arnao et al. [20].
Diﬀerent quantitities (5, 10, 20, and 25μg) of the phyto-
extracts were tested. Absorbance was taken at 734nm.
Percentage scavenging of ABTS
•+ radical was calculated by
a similar formula as used for the calculation of DPPH
•
scavenging, and also expressed in Trolox equivalence (in μg).
2.4.3. Ferric Reducing Antioxidant Property (FRAP). FRAP
assay was done according to the protocol of Benzie and
Strain [21] with some modiﬁcations. The stock solutions
were 300mM acetate buﬀer (3.1gC2H3NaO2 · 3H2O, and
16mLC2H4O2; pH 3.6), TPTZ solution (10mM TPTZ in
40mMHCl), and 20mMFeCl3 · 6H2O solution. Working
FRAP solution was prepared freshly by mixing 25mL of
acetate buﬀer, 2.5mL TPTZ solution, and 2.5mL of FeCl3 ·
6H2O solution, and then warmed to 37◦C before use.
150μL of individual extract solutions (containing 25, 50,
100, and 200μg of extracts, resp.) were allowed to react
with 2.85mL of FRAP solution for 30min in darkness.
Absorbancewasreadat593nm.Aqueoussolutionsofknown
Fe2+ concentrations (FeSO4 · 7H2O) were used to calibrate
the standard curve (Fe2+ concentration versus absorbance).
Percentage Fe3+ scavenging (reduction to Fe2+)w a sc a l c u -
lated by comparison with the standard curve. Percentage
scavenging was also evaluated in Trolox equivalence (in μg).
2.4.4. Lipid Peroxidation Inhibition Eﬃciency. Inhibition
eﬃciency of lipid peroxidation (LPI) was estimated by
thiobarbituric acid (TBA) assay [22]. A 6-week-old female
Wistaralbinoratweighingapproximately150gwasdissected
under ethereal anesthesia and its liver was excised. A liver
homogenate of 10% (w/v) was prepared in Dulbecco’s PBS
(Ca2+/Mg2+-free) (pH 7.4), and centrifuged at 503g for
15min to obtain a clear supernatant. Diverse concentrations
of each extract were taken in diﬀerent test tubes and
evaporated to dryness at 80◦C. 1mL of 0.15M potassium
chloride and 0.5mL of the obtained supernatant were added
toeachtube.Lipid peroxidation wasinitiated bytheaddition
of100μLof0.2mMferricchlorideandincubatedat37◦Cfor
30min. 2mL of ice-cold 0.25N hydrochloric acid containing
15% trichloroacetic acid and 0.38% TBA was added to stop
the peroxidation reaction, followed by incubation for 1h at
80◦C. The samples were brought down to room temperature
and centrifuged at 3144g for 15min. Absorbance of the
supernatant was measured at 532nm.Evidence-Based Complementary and Alternative Medicine 3
Percentage LPI was calculated by the following formula:
%L P I=

AC −A
A
×100

,( 2 )
where Ac is the absorbance of the control and A is the
absorbance of sample. LPI of the extracts were compared
with that of BHT and expressed in BHT equivalence. The
experiment was performed with the approval of the institu-
tional animal ethical committee (PSGIMSR/27.02.2008) and
was in accordance with the “Principles of Laboratory Animal
Care” (NIH publication #85–23, revised in 1985) [23].
2.4.5. Test for Inhibition of Cr(VI)-Induced DNA Damage
by the Extracts. Eﬃciency of the extracts as potential DNA
protectors against Cr(VI)-induced genotoxicity was tested
by treating pBR322 plasmid DNA with CrO3 in presence
of UV radiation (8000μWcm −2). 1μL aliquots of pBR322
(200μgmL
−1) were taken in four polyethylene microcen-
trifuge tubes. 50μg of each extract was separately added to
two individual tubes—SM (sample with methanolic extract)
and SA (sample with aqueous extract). The remaining two
tubes were kept without addition of any extract, and served
as controls. 5μLo f1 0μMCrO 3 was added to both SM and
SA and in one of the control tubes (now designated CCr). The
other control tube was left without addition of CrO3 and was
designated as C0.C Cr,S M,a n dS A tubes were then placed
directly on the surface of a UV transilluminator (300nm)
and irradiated for 15min at room temperature. All DNAs
(C0,C Cr,S M,a n dS A) were run on 1% agarose gel (stained
with 10μgμL
−1 ethidium bromide solution) and pho-
tographed on Lourmat Gel Imaging System (Vilbar, France).
2.4.6. Test for Inhibition of Cr(VI)-Induced Cytotoxicity
by the Extracts: XTT Assay. Inhibition of Cr(VI)-induced
cytotoxicity by the two extracts at various concentrations
was tested by the method of XTT-formazan dye formation
[24]. MDA-MB-435S cells cultured in L-15 (Leibovitz) cell
culture medium (with 10% serum) were seeded (200μL,
6 × 103 cells/well) in a 96-well plate and allowed to grow
for 24h at 37◦C. After incubation, medium was removed
from all wells. 200μL fresh medium was added to the control
w e l l s .C e l l si ne a c ht e s tw e l lw e r et r e a t e dw i t h1 0μMCrO 3
(prepared in medium) along with diﬀerent extract dosages
(0, 125, 250, 500, and 1000μg). Cells in both control and
test wells were re-incubated for 24h maintaining the same
conditions. After the treatment incubation period, medium
in each well was substituted by 200μLo ff r e s hm e d i u m
followed by the addition of 50μL of XTT (0.6mgmL
−1)
containing 25μMPMS. The plate was further incubated for
4h in the same conditions. Absorbance was measured at
450nm(witha630nmreferenceﬁlter)inaDynexOpsysMR
Microplate Reader (Dynex Technologies, VA, USA).
Percentage cytotoxicity was calculated by the following
formula:
%cytotoxicity =
(AC −AT )
AC

× 100, (3)
whereAC is the mean absorbance of the control wells and AT
is the mean absorbance of test wells with a particular extract
dosage.
2.5. Analysis of Phenolic Contents
2.5.1. Estimation of Total Phenolic Content. Total phenolic
content of the two extracts of L. inermis was determined
using the Folin-Ciocalteau reagent method [25]. To 50μLo f
each extract of diﬀerent concentrations (125, 250, 500, and
1000μg), 2.5mL of Folin-Ciocalteau reagent (1/10 dilution)
and 2mL of 7.5% Na2CO3 (w/v) were added and mixed
well. The blend was incubated at 45◦C for 15min. The
absorbances of all samples were measured at 765nm with
Na2CO3 solution (2mL of 7.5% Na2CO3 in 2.55mL of
distilled water) as blank. The results were expressed as GAE
(gallic acid equivalence) in μg.
2.5.2. Determination of Phenolic Compounds: HPLC Analysis.
HPLC analysis was performed using a Waters 2487 HPLC
system consisting of a dual λ detector and a Waters 1525
binary pump, and equipped with a Waters Symmetry C18
column (5μm, 4.6 × 150mm) with Waters Sentry universal
guard column (5μm, 4.6 × 20mm) (Waters Corporation,
Milford, MA, USA). Phenolic compounds in the aqueous
and methanolic extracts of L. inermis were analyzed using
the reference HPLC method [26]. Gradient elution was per-
formed at 35◦C with solution A (50mM sodium phosphate
in 10% methanol; pH 3.3) and solution B (70% methanol)
in the following gradient elution program: 0–15min—100%
of Solution A; 15–45min—70% of Solution A; 45–65min—
65% of Solution A; 65–70min—60% of Solution A; 70–
95min—50%ofSolutionA;95–100min—0%ofSolutionA.
Flow rate was 1mLmin−1 and injection volume was 20μL.
Detection was monitored at diverse wavelengths (around
λmax) for various phenolic compounds, that is, 250nm for
benzoic acids, isoﬂavones and most anthraquinones; 280nm
for some ﬂavones, ﬂavanones, catechins, theaﬂavins and
some anthraquinones; 320nm for cinnamic acids, most
ﬂavones and chalcones; 370nm for ﬂavonols; 510nm for
anthocyanins [26].
2.6. Statistical Analysis. All analyses were carried out in
triplicates. Data were presented as mean ± standard devi-
ation (SD). Statistical analyses were performed by one-
way ANOVA. Signiﬁcant diﬀerences between groups were
determined at P<. 05. To evaluate relationships between
experimental parameters, results were analyzed for correla-
tion and regression and tested for signiﬁcance by Student’s
t-test (P<. 05). MATLAB ver. 7.0 (Natick, MA, USA),
SPSS ver. 9.05 (Chicago, IL, USA) and Microsoft Excel 2007
(Roselle, IL, USA) were used for the statistical and graphical
evaluations.
3. Results
3.1. Antioxidant Potential. DPPH
• is a stable free radical
whose absorbance (λmax = 517nm) decreases when antioxi-
dants donate protons to DPPH
• [19]. Quantitative analysis4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Antioxidant potential of aqueous and methanolic extracts of L. inermis. Data expressed are as mean ± SD (n = 3, P<. 05). (a)
PercentageDPPH
• radicalscavengingpotentialwithTroloxequivalence(inμgmL
−1).(b)PercentageABTS
•+ radicalscavengingactivitywith
Trolox equivalence (in μg). (c) Percentage Fe3+ reducing potential with Trolox equivalence (in μg). (d) Percentage LPI by L. inermis extracts
with BHT equivalence (in μg).
revealed strong DPPH
• radical scavenging ability in both
the aqueous and methanolic extracts. Figure 1(a) shows the
mean (±SD at P<. 05) values of percentage DPPH
•-
scavenging for diﬀerent dosages of the two extracts along
with Trolox equivalence.
Figure 1(b) depicts the percentage scavenging of ABTS
•+
radical by the two extracts and along with Trolox equivalence
(in μg). Both extracts showed high antioxidant property,
which was in qualitative congruity to the results of the DPPH
assay. Quantitatively, however, radical scavenging eﬃciency
was considerably higher in the ABTS assay in comparison to
DPPH assay.
Results of the FRAP assay (Figure 1(c)) showed that
the aqueous extract was a stronger Fe3+-reductant than the
methanolic extract. Moreover, both extracts showed consid-
erably lesser antioxidant potential in FRAP in comparison to
both DPPH and ABTS assays.
All three radical-scavenging assays showed signiﬁcant
mutual positive correlation at P<. 05. Coeﬃcient of deter-
mination (R2) values between DPPH and ABTS, ABTS and
FRAP, and DPPH, and FRAP are 0.96, 0.98, and 0.99,
respectively.
Intracellular and membrane lipids, when subjected to
considerable oxidative stress, lose a hydrogen atom from
an unsaturated fatty acyl chain, thus initiating lipid perox-
idation which propagates as a chain reaction. This leads to
the generation of diverse peroxides and cyclic endoperoxides
which consequently form malondialdehyde (MDA). On
reacting with TBA, MDA produces a pink chromogen with
highest absorbance at 532nm, thus providing an estimate
of LPI [22]. Figure 1(d) shows a dose-dependent inhibition
of lipid peroxidation (by both extracts) along with BHT
equivalence (in μg).
3.2. Inhibition of Cr(VI)-Induced DNA Damage. Cr(VI)
causes DNA damage involving adducts, breaks, and cross-
linksandinhibitsrepairofDNAdamageinducedbyUV[27].
Figure 2 shows the electrophoretic pattern of pBR322 DNA
following exposure to Cr(VI)-UV. Normal pBR322 (C0)
showedthreebandsonagarosegelelectrophoresis.ThefasterEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀect of L. inermis extracts (50μg) on the protection
of DNA (plasmid pBR322) against oxidative damage caused by
exposure to Cr(VI) (10μMC r O 3) and UV radiation. C0 = normal
without Cr(VI)-UV exposure and extract treatment (control); CCr
= DNA with Cr(VI)-UV exposure and without extract treatment
(control); SM = DNA with Cr(VI)-UV exposure, methanolic extract
treated; SA = DNA with Cr(VI)-UV exposure, aqueous extract
treated; scDNA = supercoiled DNA; ocDNA = open circular DNA;
linDNA = linear DNA.
moving band represented the native form of supercoiled cir-
cular DNA (scDNA), the slower moving band corresponded
to the open circular form (ocDNA), and the intermediate
band designates linear DNA (linDNA) [28]. Cr(VI)-UV-
exposurecausedabsolutedamagetopBR322DNA(nobands
visible) in CCr.S A demonstrated comparatively robust bands
than SM.S A showed a banding pattern consisting of a faint
linDNA band and a prominent scDNA band, although the
band corresponding to ocDNA was lacking. SM, on the other
hand, showed very faint scDNA band with the ocDNA and
linDNA totallyobliterated. However, both SA andSM showed
some magnitude of DNA protection in comparison to CCr.
This suggested that both extracts showed varying degrees
of potential in inhibiting DNA damage due to Cr(VI)-UV
exposure, the aqueous extract being a better DNA-protector
than the methanolic.
3.3. Inhibition of Cr(VI)-Induced Cytotoxicity. Live cells
metabolically reduce XTT to a soluble product XTT-
formazan, which can be estimated spectrophotometrically as
a measure of cell viability [24]. Figure 3 shows the protective
eﬀects of the aqueous and methanolic extracts on Cr(VI)-
induced cytotoxicity in MDA-MB-435S cells as determined
by XTT assay. Cells treated with only Cr(VI) were subjected
toseverelyhightoxicity.However,cytotoxicitywaseﬀectively
mitigated in Cr(VI)-treated cells by action of aqueous and
methanolic extracts of L. inermis in a dosage-dependent
pattern.
3.4. Phenolic Contents
3.4.1. Estimation of Total Phenolic Content. Phenolic com-
pounds can be deﬁned as a large series of chemical
constituents possessing at least one aromatic ring bearing
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Figure 3: Dosage-dependent inhibition of Cr(VI)-induced cyto-
toxicity in MDA-MB-435S (human breast carcinoma) cells by
aqueous and methanolic extracts of L. inermis as estimated by
XTT assay. Sample cells were treated with 10μMC r ( V I )f o r2 4
h with the following extract-dosages: (A): 0μg; (B): 125μg; (C):
250μg; (D): 500μg; (E): 1000μg. Control cells (without Cr and/or
e x t r a c tt r e a t m e n t )w e r eu s e da sr e f e r e n c ef o re v a l u a t i n gp e r c e n t a g e
cytotoxicity. Values given are as mean ± SD for n = 3 samples
(P<. 05).
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Figure 4: Total phenolic content in varying concentrations of L.
inermis extracts. Data is given in mean ± SD for n = 3 samples
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hydroxyl and other subconstituents, including their func-
tional derivatives [29]. Variations in the quantity of total
phenolics in the two extracts are presented in Figure 4.
Quantitative estimation proved that both extracts have
considerably high constitutions of phenolic compounds that
increase with extract dosage. Total phenolic content, which6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Relationship between total phenolic content of aqueous and methanolic extracts of L. inermis and (a) ABTS
•+ radical scavenging
potential. (b) DPPH
• radical scavenging eﬃciency. (c) Fe3+ reducing potential. (d) LPI. (e) Cell viability against Cr(VI)-induced toxicity. All
parameters show strong and signiﬁcant positive correlation with total phenolic content (at P<. 05) for both extracts.Evidence-Based Complementary and Alternative Medicine 7
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Figure 6: Animated hypothetical diagram representing the mode of action of L. inermis extracts against Cr(VI)-induced cytotoxicity. (a)
Cr(VI) cross-links DNA and causes oxidative damage to DNA and lipids, consequently leading to cell death. (b) L. inermis extracts provide
a barrier against Cr(VI) toxicity cascade by virtue of antioxidant eﬃcacies, thereby ensuring cell viability.
was expressed in GAE in μg, demonstrated a much enhanced
phenolic composition of both extracts than the gallic acid
standard.
Phenolic compounds have been found to encounter
heavy metal-induced stress in plants [30]. Further, phenolic
compounds are also known for their antioxidant, anti-
mutagenic and anti-tumor activities [31]. To check whether
the phenolic content of the two extracts can be accredited
for their antioxidant potential and their property to inhibit
Cr(VI)-inducedcytotoxicity,correlationandregressionanal-
yses were performed. Total phenolic content of both extracts
showed signiﬁcant and strong positive correlation (P<
.05) with free radical scavenging eﬃciency (DPPH, ABTS
and FRAP assays), potential of LPI (TBA assay) and prop-
erty of inhibition of Cr(VI)-induced oxidative cytotoxicity
(Figure 5).
3.4.2. Determination of Phenolic Compounds: HPLC Analysis.
Due to the diversity and complexity of natural phenolic
compounds, it is hard to characterize every compound and
elucidate its structure [13]. The major types of phenolic
compoundsinthetwoextractsofL.inermisweredetermined
by HPLC analysis. A library of the analytical characteristics
(λmax, retention time, determining λ, slope and limit cali-
bration) of more than 100 phenolic standards established by
Sakakibaraetal.[26]wasusedasthereferenceforcompound
identiﬁcation. Table 1 shows the major phenolic compounds
in the two extracts.
4. Discussion
Aqueous and methanolic extracts of L. inermis showed con-
siderable antioxidant potential in all the analytical studies.
TheresultsoftheDPPH,ABTSandFRAPassayswereincon-
gruity with those previously reported [13], and additionally,
proved a dosage-dependent increase in antioxidant potential
over diﬀerent ranges with distinct extract-speciﬁc eﬃcien-
cies. The diﬀerential scavenging activities of the extracts
againstDPPH
•,AB TS
•+,andFe 3+ radicalsmaybereferredto
thediﬀerentmechanismsoftheradical-antioxidantreactions
in these assays. The stoichiometry of reactions between the
antioxidant compounds in the extracts and the DPPH
•,
ABTS
•+,a n dF e 3+ radicals is distinctively dissimilar, which
may be inferred as a reason for the diﬀerence in scavenging
potential. The diversity in radical scavenging shown in these
assays may also be due to factors like stereoselectivity of the
radicalsorthediﬀerentialsolubilityoftheextracts[32]inthe
three testing systems. Therefore, the considerable diﬀerence
in antioxidant eﬃciency for both extracts among the three
models is justiﬁed.8 Evidence-Based Complementary and Alternative Medicine
Table 1: Major phenolic compounds present in aqueous and
methanolic extracts of L. inermis as determined by HPLC.
Phenolic compounds
Lawsonia
inermis aqueous
extract
Lawsonia
inermis
methanolic
extract
Simple polyphenols
Chlorogenic acid
(caﬀeoylquinic acid) + −
Ferulic acid + −
Gallic acid + +
Isoferulic acid + −
m-coumaric acid + −
o-coumaric acid + −
p-hydroxybenzoic acid − +
Flavonoids (ﬂavones, ﬂavonols,
and ﬂavanones)
7, 4 -dihydroxyﬂavone + −
Apigenin + −
Flavone + −
Flavonol + −
Kaempferol + −
Luteolin + −
Luteolin-7-O-glucoside + −
Myricetin + −
Naringenin-7-O-rutinoside − +
Quercetin + −
Vitexin-2 -O-rhamnoside + −
Catechins
(+)—catechin + −
(−)—catechin gallate + −
(−)—epicatechin gallate + −
Chalcones
Butein + −
Chalcone + −
Phloretin + −
Anthocyanins
Cyanidin + −
Cyanidin-3-O-rutinoside + −
Pelargonidin + −
Ap r e v i o u ss t u d y[ 33] reported that aqueous solution of
commercially available L. inermis powder did not show any
prominent inhibition of lipid peroxidation (i.e., no decrease
in the level of MDA in test samples in comparison to an
untreated control group) in the liver cells of female Swiss
albino rats. The results of the present study, however, showed
considerable diﬀerence in results, and found both extracts
eﬃcient in this precinct. Treatment by both extracts showed
a signiﬁcant (P<. 05) dosage-dependent increase in the
capacity to inhibit lipid peroxidation in the rat liver cells.
Thereasonforthisdiﬀerenceinresultsmightbeattributedto
the presence of toxic substances like para-phenylenediamine
(PPD), nickel, cobalt, and so forth. in commercially available
L. inermis powder [34] which was used for the previous
study [33]; and hence it might not have inhibited lipid
peroxidation.
pBR322 DNA was protected by both extracts against
10μM Cr(VI) in presence of UV radiation. Although such a
protectivepotentialisextensivelydependentonthedosageof
both Cr(VI) and the extracts, it is evident that both aqueous
and methanolic extracts demonstrated variable magnitudes
of DNA protection against Cr(VI)-induced oxidative stress
which completely damaged DNA in absence of any extract
(i.e., in CCr).
A steady decline was noted in the magnitude of Cr(VI)-
induced cytotoxicity in MDA-MB-435S cells with increasing
dosage of the extracts in the XTT assay. The aqueous extract
proved to be a considerably better cyto-protective agent in
comparison to the methanolic extract at 125, 250, and 500μg
dosages. At 1000μg, however, both extracts showed almost
identical levels of protection to the cells, with the aqueous
extract minutely ahead of its counterpart. ROS causes
oxidative damage to genomic DNA, mtDNA, lipids (lipid
peroxidation) and proteins, and leads to cellular dysfunction
and/orcelllossthroughenergydeﬁcitandapoptosis[10,35].
Cr(VI), being an eﬃcient generator of ROS [9], thereby
causes considerable cytotoxicity to cells through free radical-
mediated oxidative cascades [11, 12]. Both aqueous and
methanolicextractsofL.inermishavedemonstratedeﬀective
potential in free radical scavenging and lipid peroxidation
inhibition, by virtue of which they may have been able to
countertheoxidativestressgeneratedinMDA-MB-435Scells
by Cr(VI).
Phenolic content of both extracts showed signiﬁcant
correlation with free radical scavenging, LPI and cytoprotec-
tivepotential againstCr(VI)-inducedtoxicity.HPLCanalysis
revealedpresenceofavarietyofphenoliccompoundsinboth
extracts which might have been responsible for their eﬀective
therapeuticpotentialsasreportedbythisstudy.However,itis
interesting to note that the diversity of phenolic compounds
in the aqueous extract is colossally more in comparison to
that of the methanolic extract.
Inconclusion,itcanbeinferredthataqueousandmetha-
nolic extracts of L. inermis have high antioxidant potential
(by virtue of their diverse phenolic constituents) which
simultaneously inhibits Cr(VI)-induced oxidative toxicity to
MDA-MB-435S cells and pBR322 DNA. Hence, the tested
extracts inhibit the oxidative damage pathway induced by
Cr(VI), and thereby prevent cell death (Figure 6). The plant
can serve as a prospective source of natural phenolics and
o t h e rm e t a b o l i t e sw h i c hc o u l dp r o v et ob ep r e c u r s o r sf o r
designing eﬀective drugs against heavy metal toxicity.
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